Plasmatech Biopharmaceuticals Inc


Roth Capital Offers Insight on Plasmatech Biopharmaceuticals Inc Following Blood Disorder Program Licensing

Roth Capital analyst Elemer Piros offered commentary on Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) following the licensing of a program to treat a wide variety of rare blood …

Thursday Insights: MannKind Corporation (MNKD), Plasmatech Biopharmaceuticals Inc (PTBI), Tokai Pharmaceuticals Inc (TKAI), Box Inc (BOX)

MannKind Corporation (NASDAQ:MNKD) shares are tumbling 6.87% in mid-day trading to $5.

Roth Capital Initiates Buy on Plasmatech Biopharmaceuticals Inc; Sees 100% Upside For The Stock

Roth Capital analyst Elemer Piros initiated coverage on Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) after looking at the company’s world-class gene and protein therapeutics portfolio for …

Company Update (NASDAQ:PTBI): Plasmatech Biopharmaceuticals Inc Announces License Agreement For AAV Gene Therapy To Treat Juvenile Batten Disease

Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases …

Monday Morning Pre-Market Insights: MannKind Corporation (MNKD), Seadrill Ltd (SDRL), Receptos Inc (RCPT), Plasmatech Biopharmaceuticals Inc (PTBI)

MannKind Corporation (NASDAQ:MNKD) shares increased more than 2% in pre-market trading to $6.25 after Shaunak Deepak, an analyst at Jefferies, reiterated a Buy …

Plasmatech Biopharmaceuticals Inc (PTBI): “News” On Orphan Drug Status Is Hyped Up To Raise Stock Price

Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) rocketed on “news” that the FDA granted orphan drug status to its newly acquired gene therapy products. But PTBI’s …

Stock Update (NASDAQ:PTBI): Plasmatech Biopharmaceuticals Inc Closes Abeona Therapeutics Acquisition

Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI), a biopharmaceutical company focused on gene therapy and cell therapy products for severe and life-threatening rare diseases announced that …

Plasmatech Biopharmaceuticals Inc (PTBI) Is Spiking Even Higher

Plasmtech Biopharmaceuticals Inc (NASDAQ:PTBI) is spiking higher by over 60% on news that the Company has agreed to acquire Abeona Therapeutics in common …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts